Alembic Pharmaceuticals receives USFDA final approval for Ticagrelor Tablets
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 90 mg and tentative approval for Ticagrelor Tablets, 60 mg.
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Brilinta Tablets, 60 mg and 90 mg, of AstraZeneca Pharmaceuticals LP (AstraZeneca).
Ticagrelor tablets are indicated for: i) to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel. Ticagrelor tablets also reduces the risk of stent thrombosis in patients who have been stented for treatment of ACS. ii) to reduce the risk of a first MI or stroke in patients with coronary artery disease (CAD) at high risk for such events, and iii) to reduce the risk of stroke in patients with acute ischemic stroke (NIH Stroke Scale score <5) or high-risk transient ischemic attack (TIA).
For Ticagrelor Tablets, 90 mg, Alembic was one of the first ANDA applicants to submit a substantially complete ANDA with a paragraph IV certification.
Ticagrelor Tablets, 90 mg have an estimated market size of US$ 1,062 million for twelve months ending March 2025 according to IQVIA. Ticagrelor Tablets, 60 mg have an estimated market size of US$ 242 million for twelve months ending March 2025 according to IQVIA.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
2 hours ago
- NDTV
China Expert Warns Of "Something Worse" Than Covid After US Fungus Smuggling Case
Quick Read Summary is AI generated, newsroom reviewed. A US expert warns of a potential agroterrorism threat after two Chinese scientists were charged with smuggling a toxic fungus into the US, suggesting it could lead to catastrophic consequences worse than Covid if relations with China aren't severed. New Delhi: A top US-based expert on China has warned of "something worse" than Covid if the United States is not careful, days after two Chinese scientists were charged with allegedly smuggling a toxic fungus into the US. Yunqing Jian, 33, and her boyfriend Zunyong Liu, 34, allegedly conspired to smuggle into the US a fungus called 'Fusarium graminearum' that causes "head blight," a disease of wheat, barley, maize, and rice. The US Justice Department said the fungus is classified in scientific literature as a "potential agroterrorism weapon," and causes billions of dollars in losses each year. It causes vomiting, liver damage, and reproductive defects in humans and livestock. The couple had previously conducted work on the fungus in China. Referring to the case, America's top expert on Chinese affairs, Gordon G Chang, told Fox News that the couple's action amounted to waging war against the US. Chang said that if the US does not take drastic steps like cutting off ties with China, it may be hit "perhaps with something worse" than Covid. The origin of the novel coronavirus SARS-CoV-2 which caused the Covid-19 pandemic is a matter of huge controversy as some experts suspect the coronavirus was allegedly engineered in a Chinese lab. "In May 2019, the state media People's Daily, the most authoritative publication in China, carried a landmark editorial that declared a people's war on us. We are Americans, so we think we are entitled to ignore the propaganda of hostile regimes. But for a communist party, that phrase has great resonance. What they are doing with their strident anti-Americanism is creating a justification to strike our country. This means the couple, for instance, should be sent to Guantanamo," Chang told Fox News. "It was an attack on the United States at a time when China thought it was at war with us. Xi Jinping talks about going to war all the time, and he is mobilising all of Chinese society to go to war. So we can lose our country, even though we are the far stronger nation because we are not defending ourselves with the vigour and the determination that is necessary. "We have got to put this into context. In 2020, Americans in all 50 states received from China seeds that were unsolicited. I think that was an attempt to plant invasive species into the US. And then this year, Timu, the online Chinese retailer, sent seeds to Americans unsolicited. "The only way to stop this is to sever relations with China. And I know people think that's drastic, but we are being overwhelmed. We are going to get hit eventually. We are going to get hit really hard, not just with Covid, not just with fentanyl, but perhaps with something worse," the expert on China said. Change is the author of 'China Is Going to War' and several other titles. He has lived and worked in China and Hong Kong for almost two decades, most recently in Shanghai, as Counsel to the American law firm Paul Weiss and earlier in Hong Kong as Partner in the international law firm Baker & McKenzie.
Hindustan Times
2 days ago
- Hindustan Times
At least 16 Palestinians killed in Israeli strikes on Gaza, say health officials
Sixteen Palestinians were killed by the Israeli military in Gaza on Friday, according to local health authorities, as a US- and Israeli-backed group said it had handed out aid in the enclave after earlier saying that its distribution sites were closed. The military had no immediate comment on the reports of deaths in war-shattered Gaza. Health authorities said strikes had killed people in Gaza's Jabalia, Tuffah and Khan Younis areas. Witnesses and medics told Reuters that Israeli planes and tanks had intensified strikes on Jabalia and nearby Beit Hanoun since the early hours. The Israeli military issued evacuation orders to residents of certain blocks in northern Gaza on Friday, spokesperson Avichay Adraee posted on X. The U.S.-backed Gaza Humanitarian Foundation (GHF) told Reuters by email it had delivered aid on Friday, despite earlier announcing on its official Facebook page that its distribution sites were closed until further notice and that people should stay away from the sites "for their safety" after a series of deadly shootings. The GHF opened two sites in southern Gaza on Thursday after closing all of its centres the previous day in the wake of shootings in the vicinity of its operations. It has so far operated four distribution centres. The organisation bypasses traditional relief agencies and has been criticised by humanitarian organisations, including the United Nations, for alleged lack of neutrality, which it denies. Palestinians collecting aid from GHF sites told Reuters that there was no clear distribution system, describing the process as disorganised and chaotic. Footage released this week by the organisation has shown similar scenes at one of its sites. GHF halted distributions on Wednesday and said it was pressing Israeli forces to improve civilian safety beyond the perimeter of its operations after dozens of Palestinians were shot dead near the Rafah site over three consecutive days. The Israeli military said on Sunday and Monday that its soldiers had fired warning shots. On Tuesday, it said, forces also fired warning shots before firing towards Palestinians that it said were advancing towards troops. GHF has said that aid was safely handed out from its sites without any incident. Military spokesperson Avichay Adraee wrote on X on Friday that Palestinians would have 'free movement' to aid distribution sites between 06:00 and 18:00, but warned that outside those hours the area would be a 'closed military zone' and movement would pose a significant risk to life. Israel has re-intensified an offensive against Gaza's dominant Hamas militant group since breaking a two-month-old ceasefire in March in a war triggered by Hamas' cross-border attack on October 7, 2023.
Time of India
2 days ago
- Time of India
Tariffs May Impact Growth of US Cardiovascular Device Market: GlobalData
Data and analytics company GlobalData has stated that US-imposed tariffs introduced during the Trump administration are disrupting global supply chains and could impact the growth of the country's cardiovascular device market . According to the company, pulsed field ablation (PFA) systems often manufactured overseas for reasons of cost and material access are now subject to higher tariffs, leading to increased costs and uncertainty for hospitals and manufacturers. The company states that the electrophysiology market has seen significant growth in recent years, driven by advances in medical device technology. In the past year, PFA systems have rapidly gained ground, replacing other advanced electrophysiology tools. Some PFA systems have gained market traction in recent years, driven by factors such as shorter procedure times, improved clinical outcomes, and enhanced safety for patients. Boston Scientific and Medtronic have both reported strong performance in their cardiovascular portfolios, with PFA systems contributing to this growth. David Beauchamp, Medical Analyst at GlobalData, noted that continued US tariffs could dampen the strong growth of the cardiovascular device market. With the US being the largest market and PFA systems still limited to a few countries due to regulatory constraints, manufacturers may face a choice between absorbing higher costs or increasing prices. GlobalData estimates the US PFA market to be worth $535.9 million in 2024, with a projected compound annual growth rate (CAGR) of 31.65 per cent through 2034. This outlook may be affected by tariff-related cost pressures within the medical device supply chain. 'In very high-growth markets, including the PFA market, supply chain disruption and manufacturing cost increases may result in healthcare providers preferring other, cheaper options, which could result in possible slowdown for the growth of PFA systems,' said David Beauchamp
